| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $31.01M | $39.32M | $35.83M | $24.43M | $25.25M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $32.09M | $26.52M | $23.00M | $18.57M | $12.92M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | – | – | – | – | – |
| Interest Expense | $18.41M | $14.88M | $11.74M | $10.69M | $10.43M |
| Tax Expense | – | – | – | – | – |
| Net Income | -$31.79M | $3.55M | $25.33M | -$15.58M | -$10.28M |
| EPS (basic) | -2.5700 | 0.3600 | 3.3300 | -2.4900 | -2.5200 |
| EPS (diluted) | -2.5700 | 0.3600 | 3.3300 | -2.4900 | -2.5200 |
| Shares (diluted) | $12.36M | $9.84M | $7.60M | $6.25M | $4.07M |